June 28, 2025 — People living with obesity face a heavy and often hidden burden – financial, physical, social, and psychological – embedded in health systems and extending far beyond health risks. A nationally representative U.S. study reveals that one in six adults with obesity struggles to afford healthcare, routinely skipping medications or even meals to manage cost. With […]
March 13, 2025 — Over the last few decades, there have not been a lot of bright spots for metabolic health. But here’s one. A new paper in Diabetes Care tells us diabetes mortality actually dropped between 2000 and 2019. The authors, led by Hasan Nassereldine, suggest that the decline in diabetes deaths could be due to the adoption […]
March 6, 2025 — Prices are moving quickly for people seeking obesity treatment with semaglutide and tirzepatide. Last week, Lilly offered another price cut for Zepbound. At the time, we noted inaction from Novo Nordisk on this front. But it barely took a week for this formerly unchallenged market leader to step up and respond with a huge price […]
March 3, 2025 — Today marks the first day of Obesity Care Week. This is a time to recognize the importance of high-quality, science-based, and compassionate care for people living with obesity. True commitment to care means embracing advocacy, evidence-based treatment, and respect for individuals affected by this chronic disease. Organizations like the Obesity Action Coalition (OAC) and The […]
February 3, 2025 — A new study in JAMA Network Open makes one thing very clear. Most people who take GLP-1 medicines for obesity quit within a year. Most who take them for diabetes are less likely to quit. Why are the disparities in GLP-1 medicines for obesity so great in comparison to their use for diabetes? It’s all […]
January 9, 2025 — The docket is open for you to lend your support until January 27. The Center for Medicare and Medicaid Services (CMS) is proposing to open up access to obesity medicines in both of the programs they oversee. This is something that we – with virtually every advocate for obesity care – have been seeking for […]
December 11, 2024 — The 2025 Dietary Guidelines Committee released its report yesterday and the reaction to this seems to be a bit of a yawn. “More beans and less red meat” was the headline from the Associated Press. “Highly conservative (not in a good sense)” is the bottom line from Marion Nestle, Emerita Professor of Nutrition, Food Studies, […]
December 6, 2024 — The market for precision nutrition advice is more than six billion dollars today and estimated to double by the end of this decade. Sales of continuous glucose monitoring devices are on their way to $20 billion within three years. But a new study this week in the American Journal of Clinical Nutrition suggests that the […]
November 7, 2024 — We have a lot to think about. Well over 3,000 people spent the better part of the week absorbing new science and insights into obesity – not to mention a momentous election. So as everyone sets about the task of catching up with routines, here is a quick take on five thoughts about what we’re […]
November 4, 2024 — From the Presidential Plenary at ObesityWeek, a primary issue standing in the way of progress is quite clear. Are we tipping toward equity in obesity care, or are we tripping over it? Tipping Toward Progress The argument for progress comes from putting the lived experience of obesity on stage to dominate the opening plenary for […]
